Clinical trial
Guselkumab: A Real Life Non-Interventional, Persistence and Effectiveness Study in Patients With Crohn's Disease or Ulcerative Colitis
NCT07848737 is registered in ClinicalTrials.gov with Janssen-Cilag, S.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Guselkumab: A Real Life Non-Interventional, Persistence and Effectiveness Study in Patients With Crohn's Disease or Ulcerative Colitis
- Lead sponsor
- Janssen-Cilag, S.A.
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- October 30, 2026
- Completion date
- October 30, 2029
- Enrollment
- 200 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.